why choose us

First received: September 04, 2024

Clinical Trial: Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Parkinsonian Signs in Older Persons

Study Type: INTERVENTIONAL


Official Title: Neurobiological Drivers of Mobility Resilience: The Dopaminergic System

Brief Summary: Walking with age becomes both slower and less 'automated', requiring more attention and brain resources.As a result, older adults have a greater risk of negative outcomes and falls.There is an urgent need to identify factors that can help compensate for these harmful factors and reduce walking impairments, as there are currently no effective treatments available.Investigators have recently discovered that ~20% of older adults maintain fast walking speed even in the presence of small blood vessel brain…

Read more